Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
23.17
-1.01 (-4.18%)
Feb 2, 2026, 4:00 PM EST - Market closed

AAPG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,1401,8129958519321,096
Market Cap Growth
35.60%82.10%16.89%-8.64%-15.02%39.78%
Enterprise Value
2,1501,8961,0098307981,045
PS Ratio
39.2613.4831.7827.99212.05574.86
PB Ratio
22.6948.2399.8714.364.798.45
P/TBV Ratio
26.8980.87-19.595.159.47
EV/Sales Ratio
39.4214.1132.2427.31181.70548.17
Debt / Equity Ratio
2.546.0925.424.390.880.63
Asset Turnover
0.130.380.080.070.010.01
Inventory Turnover
3.702.562.383.29--
Quick Ratio
1.401.171.351.785.053.77
Current Ratio
1.541.261.441.865.223.91
Return on Equity (ROE)
-159.65%-235.32%-386.28%-107.45%-75.18%-78.02%
Return on Assets (ROA)
-22.77%-9.25%-20.92%-19.14%-24.97%-29.14%
Return on Capital Employed (ROCE)
-62.00%-26.10%-57.00%-45.30%-36.20%-47.00%
Earnings Yield
-7.56%-3.07%-13.12%-15.04%-13.22%-9.47%
FCF Yield
-1.46%-1.03%-10.95%-14.60%-17.57%-12.02%
Buyback Yield / Dilution
-12.40%-7.00%-7.07%-3.56%-17.93%-84.97%
Updated Sep 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q